Keywords: wyeth, cordarone, benefit, acls, guidelines, revision, wyeth-ayerst

Wyeth's Cordarone to benefit from ACLS guidelines revision

Article | 17 August 2000

Wyeth-Ayerst Laboratories' anti-arrhythmic drug Cordarone IV(amiodarone HCl) has been added to the American Heart Association's Advanced Cardiac Life Support ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Wyeth

Go to company listing

Related Drugs

Amiodarone HCl Tablets

Cordarone

Amiodarone

Cordarone IV

Go to drug listing